NCT00968526View on ClinicalTrials.gov

Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

September 8, 2009

Primary Completion Date

September 23, 2010

Study Completion Date

September 23, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

GSK investigational vaccine GSK2340272A

One or two intramuscular injections in the deltoid region of the non-dominant or the dominant arm.

Trial Locations (1)

2610

GSK Investigational Site, Wilrijk

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00968526 - Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults | Biotech Hunter | Biotech Hunter